Sigma drops as Boots pursuit puts focus on funding
Sigma Healthcare shares fell over 5% to A$2.76 Wednesday after confirming early talks on a possible purchase of UK pharmacy chain Boots. The move comes weeks after Sigma announced a smaller UK expansion with GreenLight Healthcare. Investors voiced concerns over deal size, funding, and integration. Australia’s main index rose 0.7%.